FDA Drug Recalls

Recalls / Class II

Class IID-0236-2017

Product

Nadolol Tablets, USP, 40mg, packaged in 1000-count bottle, Rx Only, Manufactured by Sandoz Inc., Princeton, NJ 08540, NDC 0781-1182-10

Affected lot / code info
Lot GG1539

Why it was recalled

Failed dissolution specification: recalled due to an out of specification dissolution result of 40% (Specification: NLT 80%)

Recalling firm

Firm
Sandoz Incorporated
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2555 W Midway Blvd, N/A, Broomfield, Colorado 80020-1632

Distribution

Quantity
96 bottles
Distribution pattern
MS and OH.

Timeline

Recall initiated
2016-12-22
FDA classified
2016-12-27
Posted by FDA
2017-01-04
Terminated
2017-09-18
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0236-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.